These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children. Wang X, Ding Y, Zhou Z, Hou J, Xu Y, Li J. Pediatr Rheumatol Online J; 2021 Jan 06; 19(1):6. PubMed ID: 33407621 [Abstract] [Full Text] [Related]
5. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan. Iwata N, Nakaseko H, Kohagura T, Yasuoka R, Abe N, Kawabe S, Sugiura S, Muro Y. Mod Rheumatol; 2019 Sep 06; 29(5):802-807. PubMed ID: 30092736 [Abstract] [Full Text] [Related]
7. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population. Manwatkar A, Padiyar S, Nair A, Jha A, Kumar S, Yadav B, Prakash JAJ, Das JK, Mathew J. Clin Rheumatol; 2023 Dec 06; 42(12):3289-3297. PubMed ID: 37801141 [Abstract] [Full Text] [Related]
8. Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups. Nguyen M, Do V, Yell PC, Jo C, Liu J, Burns DK, Wright T, Cai C. Acta Neuropathol Commun; 2020 Aug 05; 8(1):125. PubMed ID: 32758284 [Abstract] [Full Text] [Related]
10. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis]. Li DM, Wang L, Liu MY, Xu L, Tang XM. Zhonghua Er Ke Za Zhi; 2020 Dec 02; 58(12):966-972. PubMed ID: 33256317 [Abstract] [Full Text] [Related]
11. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis. He L. Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct 15; 23(10):1064-1068. PubMed ID: 34719424 [Abstract] [Full Text] [Related]
14. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature. Chang Y, Shan X, Ge Y. Pediatr Rheumatol Online J; 2023 Sep 21; 21(1):106. PubMed ID: 37735702 [Abstract] [Full Text] [Related]
15. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review]. Hou J, Zhou ZX, Li JG, Xu YJ, Ding YC. Zhonghua Er Ke Za Zhi; 2019 Dec 02; 57(12):928-933. PubMed ID: 31795559 [Abstract] [Full Text] [Related]
16. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series. Toplak N, Pimpale Chavan P, Rosina S, Dallos T, Rotem Semo O, Aguiar CL, Khubchandani R, Ravelli A, Patwardhan A. Front Pediatr; 2021 Dec 02; 9():810785. PubMed ID: 35280444 [Abstract] [Full Text] [Related]
17. [Juvenile dermatomyositis and new autoantibodies: Cases and review]. Guarella M, Jurquet AL, Retornaz K, Bardin N, Chastang MC, Desjonquere M, Fabien N, Belot A. Arch Pediatr; 2015 Dec 02; 22(12):1263-7. PubMed ID: 26598044 [Abstract] [Full Text] [Related]